Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis.

about

Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid-papillary carcinoma.Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification.

P2860

Q41127019-4921FAC5-C0A3-43B0-A82E-A71E909544C4 Q42377436-1B837085-890C-4A4C-A45C-4FE9B2978107

P2860

Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis.

Item

http://www.wikidata.org/entity/Q42316809

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Precise ERBB2 copy number asse ...... nversion probe array analysis.

@en

Precise ERBB2 copy number asse ...... nversion probe array analysis.

@nl

type

Item

label

Precise ERBB2 copy number asse ...... nversion probe array analysis.

@en

Precise ERBB2 copy number asse ...... nversion probe array analysis.

@nl

prefLabel

Precise ERBB2 copy number asse ...... nversion probe array analysis.

@en

Precise ERBB2 copy number asse ...... nversion probe array analysis.

@nl

P1476

Precise ERBB2 copy number asse ...... nversion probe array analysis.

@en

P2093

Brigitte Schlegelberger

http://www.w3.org/2001/XMLSchema#string

Doris Steinemann

http://www.w3.org/2001/XMLSchema#string

Friedrich Feuerhake

http://www.w3.org/2001/XMLSchema#string

Hans H Kreipe

http://www.w3.org/2001/XMLSchema#string

Jana L van Luttikhuizen

http://www.w3.org/2001/XMLSchema#string

Lars Schmidt

http://www.w3.org/2001/XMLSchema#string

Matthias Christgen

http://www.w3.org/2001/XMLSchema#string

Peter Braubach

http://www.w3.org/2001/XMLSchema#string

Ulrich Lehmann

http://www.w3.org/2001/XMLSchema#string

P2860

The Measurement of Observer Agreement for Categorical Data

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.

Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study.

Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.

Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling.

Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience.

Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program.

Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be t

P304

82733-82740

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.12421

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mieke Raap

Danny Jonigk

P577

2016-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27716627

http://www.w3.org/2001/XMLSchema#string

P932

5347728

http://www.w3.org/2001/XMLSchema#string

Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis.

about

P2860

P2860

Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932